Status:

COMPLETED

Novel Breath Test to Detect Early Stage Chronic Pancreatitis

Lead Sponsor:

Metabolic Solutions Inc.

Collaborating Sponsors:

University of Florida

Conditions:

Chronic Pancreatitis

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to evaluate the feasibility of using a non-invasive, non-radioactive Pancreatic Breath Test (PBT) as a diagnostic tool to detect early stages of chronic pancreatitis (CP). If...

Detailed Description

Disorders of the pancreas affect more than one million persons in this country with nearly $3 billion in health care costs. The incidence rate of chronic pancreatitis (CP) is rapidly increasing and ma...

Eligibility Criteria

Inclusion

  • Male of female greater than or equal to 18 years of age.
  • Subjects must have the ability to give informed consent.
  • Female subjects of child bearing potential must use a medically acceptable form of birth control and have a negative pregnancy test.
  • For case subjects with mild to moderate chronic pancreatitis, they must have either an abnormal endoscopic ultrasound (greater than 4 abnormalities), an abnormal secretin stimulation test, an abnormal endoscopic retrograde cholangiopancreatography (ERCP), an abnormal CT scan of the pancreas (dilation of the main pancreatic duct or atrophy of the pancreas), a serum trypsin level \<29 ng/ml but \>20 ng/ml, or a fecal elastase of less than 200 mcg/gram stool but greater than 100 mcg/gram stool.

Exclusion

  • Females who are lactating or pregnant.
  • Subjects with acute pancreatitis.
  • Subjects known to have a significant medical and/or mental disease.
  • Subjects receiving an investigational new drug within 30 days.
  • Subjects on enzyme therapy, proton pump inhibitors, H2 receptor antagonists.
  • Subjects who have had a recent febrile illness within 5 days of scheduled entry into the study. Body temperature must be normal for at least 72 hours before entering the study.

Key Trial Info

Start Date :

May 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2012

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01184573

Start Date

May 1 2011

End Date

September 1 2012

Last Update

February 10 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida

Gainesville, Florida, United States, 32610